244 related articles for article (PubMed ID: 18922938)
1. Agglomerative epigenetic aberrations are a common event in human breast cancer.
Novak P; Jensen T; Oshiro MM; Watts GS; Kim CJ; Futscher BW
Cancer Res; 2008 Oct; 68(20):8616-25. PubMed ID: 18922938
[TBL] [Abstract][Full Text] [Related]
2. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.
Dallosso AR; Hancock AL; Szemes M; Moorwood K; Chilukamarri L; Tsai HH; Sarkar A; Barasch J; Vuononvirta R; Jones C; Pritchard-Jones K; Royer-Pokora B; Lee SB; Owen C; Malik S; Feng Y; Frank M; Ward A; Brown KW; Malik K
PLoS Genet; 2009 Nov; 5(11):e1000745. PubMed ID: 19956686
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Methylation Analysis of the PCDHB Gene Cluster.
Banelli B; Romani M
Methods Mol Biol; 2015; 1315():189-200. PubMed ID: 26103900
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide survey reveals dynamic widespread tissue-specific changes in DNA methylation during development.
Liang P; Song F; Ghosh S; Morien E; Qin M; Mahmood S; Fujiwara K; Igarashi J; Nagase H; Held WA
BMC Genomics; 2011 May; 12(1):231. PubMed ID: 21569359
[TBL] [Abstract][Full Text] [Related]
7. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
Rauscher GH; Kresovich JK; Poulin M; Yan L; Macias V; Mahmoud AM; Al-Alem U; Kajdacsy-Balla A; Wiley EL; Tonetti D; Ehrlich M
BMC Cancer; 2015 Oct; 15():816. PubMed ID: 26510686
[TBL] [Abstract][Full Text] [Related]
8. Aerobic exercise training resets the human skeletal muscle methylome 10 years after breast cancer treatment and survival.
Gorski PP; Raastad T; Ullrich M; Turner DC; Hallén J; Savari SI; Nilsen TS; Sharples AP
FASEB J; 2023 Jan; 37(1):e22720. PubMed ID: 36542473
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.
Versmold B; Felsberg J; Mikeska T; Ehrentraut D; Köhler J; Hampl JA; Röhn G; Niederacher D; Betz B; Hellmich M; Pietsch T; Schmutzler RK; Waha A
Int J Cancer; 2007 Aug; 121(3):547-54. PubMed ID: 17415710
[TBL] [Abstract][Full Text] [Related]
10. Clustered protocadherins methylation alterations in cancer.
Vega-Benedetti AF; Loi E; Moi L; Blois S; Fadda A; Antonelli M; Arcella A; Badiali M; Giangaspero F; Morra I; Columbano A; Restivo A; Zorcolo L; Gismondi V; Varesco L; Bellomo SE; Giordano S; Canale M; Casadei-Gardini A; Faloppi L; Puzzoni M; Scartozzi M; Ziranu P; Cabras G; Cocco P; Ennas MG; Satta G; Zucca M; Canzio D; Zavattari P
Clin Epigenetics; 2019 Jul; 11(1):100. PubMed ID: 31288858
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
[TBL] [Abstract][Full Text] [Related]
12. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
Clark SJ
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
[TBL] [Abstract][Full Text] [Related]
13. Placentas from pregnancies conceived by IVF/ICSI have a reduced DNA methylation level at the H19 and MEST differentially methylated regions.
Nelissen EC; Dumoulin JC; Daunay A; Evers JL; Tost J; van Montfoort AP
Hum Reprod; 2013 Apr; 28(4):1117-26. PubMed ID: 23343754
[TBL] [Abstract][Full Text] [Related]
14. CpG island hypermethylation in human astrocytomas.
Wu X; Rauch TA; Zhong X; Bennett WP; Latif F; Krex D; Pfeifer GP
Cancer Res; 2010 Apr; 70(7):2718-27. PubMed ID: 20233874
[TBL] [Abstract][Full Text] [Related]
15. HOXD13 methylation status is a prognostic indicator in breast cancer.
Zhong Z; Shan M; Wang J; Liu T; Xia B; Niu M; Ren Y; Pang D
Int J Clin Exp Pathol; 2015; 8(9):10716-24. PubMed ID: 26617782
[TBL] [Abstract][Full Text] [Related]
16. Identification of epigenetic modulators in human breast cancer by integrated analysis of DNA methylation and RNA-Seq data.
Zhou X; Chen Z; Cai X
Epigenetics; 2018; 13(5):473-489. PubMed ID: 29940789
[TBL] [Abstract][Full Text] [Related]
17. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
Lin X; Nelson WG
Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
[TBL] [Abstract][Full Text] [Related]
18. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
19. Effects of methylation on expression of TMS1/ASC in human breast cancer cells.
Levine JJ; Stimson-Crider KM; Vertino PM
Oncogene; 2003 May; 22(22):3475-88. PubMed ID: 12776200
[TBL] [Abstract][Full Text] [Related]
20. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
